HIGHLIGHTS
- who: November and colleagues from the Central South University, China have published the paper: M6A regulator-mediated immune in ltration and methylation modi cation in hepatocellular carcinoma microenvironment and immunotherapy, in the Journal: (JOURNAL)
- what: Considering the analysis results of the four algorithms, it is reasonable to assume that the low-risk group may be more responsive to immunotherapy. The authors describe a methylation regulatory network by recruiting 35 m6A regulators: nine writers, 23 readers, and three erasers that have been reported in the previous literature works.
- how: The authors explored the predictive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.